122 related articles for article (PubMed ID: 38678852)
1. Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson's Disease: A machine learning study.
Bianco MG; Cristiani CM; Scaramuzzino L; Sarica A; Augimeri A; Chimento I; Buonocore J; Parrotta EI; Quattrone A; Cuda G; Quattrone A
Parkinsonism Relat Disord; 2024 Jun; 123():106978. PubMed ID: 38678852
[TBL] [Abstract][Full Text] [Related]
2. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
[TBL] [Abstract][Full Text] [Related]
3. Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning.
De Vos M; Prince J; Buchanan T; FitzGerald JJ; Antoniades CA
Gait Posture; 2020 Mar; 77():257-263. PubMed ID: 32078894
[TBL] [Abstract][Full Text] [Related]
4. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
[TBL] [Abstract][Full Text] [Related]
5. A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study.
Quattrone A; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Morelli M; Nigro S; Vescio B; Bianco MG; Vasta R; Arcuri PP; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
Mov Disord; 2021 Mar; 36(3):681-689. PubMed ID: 33151015
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.
Quattrone A; Bianco MG; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Tedeschi G; Tessitore A; Cilia R; Morelli M; Nigro S; Vescio B; Arcuri PP; De Micco R; Cirillo M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
Mov Disord; 2022 Jun; 37(6):1272-1281. PubMed ID: 35403258
[TBL] [Abstract][Full Text] [Related]
7. Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy.
Talai AS; Ismail Z; Sedlacik J; Boelmans K; Forkert ND
Clin Neuroradiol; 2019 Dec; 29(4):605-614. PubMed ID: 30218110
[TBL] [Abstract][Full Text] [Related]
8. Differentiating between common PSP phenotypes using structural MRI: a machine learning study.
Quattrone A; Sarica A; Buonocore J; Morelli M; Bianco MG; Calomino C; Aracri F; De Maria M; Vescio B; Vaccaro MG; Quattrone A
J Neurol; 2023 Nov; 270(11):5502-5515. PubMed ID: 37507502
[TBL] [Abstract][Full Text] [Related]
9. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
Mangesius S; Mariotto S; Ferrari S; Pereverzyev S; Lerchner H; Haider L; Gizewski ER; Wenning G; Seppi K; Reindl M; Poewe W
Parkinsonism Relat Disord; 2020 Aug; 77():57-63. PubMed ID: 32622301
[TBL] [Abstract][Full Text] [Related]
10. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
[TBL] [Abstract][Full Text] [Related]
11. Track density imaging in progressive supranuclear palsy: A pilot study.
Nigro S; Bianco MG; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Augimeri A; Quattrone A
Hum Brain Mapp; 2019 Apr; 40(6):1729-1737. PubMed ID: 30474903
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism.
Heim B; Mangesius S; Krismer F; Wenning GK; Hussl A; Scherfler C; Gizewski ER; Schocke M; Esterhammer R; Quattrone A; Poewe W; Seppi K
Parkinsonism Relat Disord; 2021 Jan; 82():87-91. PubMed ID: 33271461
[TBL] [Abstract][Full Text] [Related]
13. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
Azuma M; Hirai T; Nakaura T; Kitajima M; Yamashita S; Hashimoto M; Yamada K; Uetani H; Yamashita Y; Wang Y
J Neurol Sci; 2019 Nov; 406():116443. PubMed ID: 31634718
[TBL] [Abstract][Full Text] [Related]
14. Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy.
Ghourchian S; Mousavi A; Zamani B; Shahidi G; Rohani M
Clin Neurol Neurosurg; 2019 Aug; 183():105383. PubMed ID: 31181432
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.
Archer DB; Mitchell T; Burciu RG; Yang J; Nigro S; Quattrone A; Quattrone A; Jeromin A; McFarland NR; Okun MS; Vaillancourt DE
Mov Disord; 2020 Aug; 35(8):1388-1395. PubMed ID: 32357259
[TBL] [Abstract][Full Text] [Related]
16. Cortical atrophy distinguishes idiopathic normal-pressure hydrocephalus from progressive supranuclear palsy: A machine learning approach.
Bianco MG; Quattrone A; Sarica A; Vescio B; Buonocore J; Vaccaro MG; Aracri F; Calomino C; Gramigna V; Quattrone A
Parkinsonism Relat Disord; 2022 Oct; 103():7-14. PubMed ID: 35988437
[TBL] [Abstract][Full Text] [Related]
17. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
Talai AS; Sedlacik J; Boelmans K; Forkert ND
Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
[TBL] [Abstract][Full Text] [Related]
18. The utility of quantitative MRI parameters in discriminating progressive supranuclear palsy from Parkinson's disease.
Onder H; Kocer BG; Turan A; Comoglu S
Neurol Res; 2023 Aug; 45(8):738-744. PubMed ID: 37068211
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
